Once-daily semaglutide 25 mg or 50 mg is superior to 14 mg for glycemic control among adults with type 2 diabetes, according to a study published online June 25 in The Lancet.
Aug 6, 2023
0
8
An analysis of 19 causes of death in the United States has revealed persistent disparities and a familiar pattern across five racial-ethnic groups and 3,110 counties from 2000 to 2019. That's according to peer-reviewed research ...
Aug 3, 2023
4
1
In the 1990s, two hurricanes devastated Samoa in the South Pacific Ocean, wiping entire communities off the map and killing dozens of people. "Everything was just decimated," Malama Tafuna'i, a primary care physician in Apia, ...
Aug 3, 2023
0
1
More than 100 medical journals across the world issued a rare joint call on Thursday for urgent action to eliminate nuclear weapons, warning that the threat of nuclear catastrophe was "great and growing".
Aug 3, 2023
0
29
UC Davis Comprehensive Cancer Center has taken part in testing the anti-cancer drug everolimus as part of a phase III clinical trial to see if it helped people with kidney cancer. Results from the clinical trial showed that ...
Jul 31, 2023
0
30
People living with HIV who maintain low—but still detectible—levels of the virus and adhere to their antiretroviral regimen have almost zero risk of transmitting it to their sexual partners, according to an analysis published ...
Jul 29, 2023
0
19
Researchers at the University of São Paulo (USP) in Brazil have identified a new class of molecules capable of stopping the excessive inflammation typical of the severe form of COVID-19 without impairing the immune response ...
Jul 25, 2023
0
38
A national Australian tax on sugary drinks could prevent more than 500,000 dental cavities and increase health equity over 10 years, a Monash University-led study has found.
Jul 24, 2023
0
2
A trio of infectious diseases specialists with Global Health Impact Group, working with a doctor from Switzerland, has found evidence suggesting that people infected with the HIV virus who have a viral load below 1,000 cpy/mL ...
For patients with refractory metastatic colorectal cancer, fruquintinib treatment yields a significant and clinically meaningful benefit in terms of overall survival, according to a study published in the July 1 issue of ...
Jul 20, 2023
0
1
